Literature DB >> 34099790

Comparative effectiveness of pharmacological interventions to prevent postoperative delirium: a network meta-analysis.

Sun-Kyung Park1, Taeyoon Lim1, Hyeyeon Cho1, Hyun-Kyu Yoon1, Ho-Jin Lee1, Ji-Hyun Lee1, Seokha Yoo1, Jin-Tae Kim1, Won Ho Kim2.   

Abstract

Many pharmacologic agents were investigated for the effect to prevent delirium. We aimed to comprehensively compare the effect of the pharmacological interventions to prevent postoperative delirium. A Bayesian network meta-analysis of randomized trials was performed using random effects model. PubMed, the Cochrane Central Register of Controlled Trials, and Embase were searched on 20 January 2021. Randomized trials comparing the effect of a drug to prevent postoperative delirium with another drug or placebo in adult patients undergoing any kind of surgery were included. Primary outcome was the postoperative incidence of delirium. Eighty-six trials with 26,992 participants were included. Dexmedetomidine, haloperidol, and atypical antipsychotics significantly decreased the incidence of delirium than placebo [dexmedetomidine: odds ratio 0.51, 95% credible interval (CrI) 0.40-0.66, moderate quality of evidence (QOE); haloperidol: odds ratio 0.59, 95% CrI 0.37-0.95, moderate QOE; atypical antipsychotics: odds ratio 0.27, 95% CrI 0.14-0.51, moderate QOE]. Dexmedetomidine and atypical antipsychotics had the highest-ranking probabilities to be the best. However, significant heterogeneity regarding diagnostic time window as well as small study effects precludes firm conclusion.

Entities:  

Year:  2021        PMID: 34099790     DOI: 10.1038/s41598-021-91314-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  102 in total

1.  Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial.

Authors:  Kenneth A Larsen; Susan E Kelly; Theodore A Stern; Robert H Bode; Lori Lyn Price; David J Hunter; Diane Gulczynski; Benjamin E Bierbaum; Gerard A Sweeney; Karen A Hoikala; James J Cotter; Adam W Potter
Journal:  Psychosomatics       Date:  2010 Sep-Oct       Impact factor: 2.386

2.  Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial*.

Authors:  Wei Wang; Hong-Liang Li; Dong-Xin Wang; Xi Zhu; Shuang-Ling Li; Gai-Qi Yao; Kai-Sheng Chen; Xiu-E Gu; Sai-Nan Zhu
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

3.  Reduction in the incidence of acute kidney injury after aortic arch surgery with low-dose atrial natriuretic peptide: a randomised controlled trial.

Authors:  Yosuke Mori; Takaaki Kamada; Ryoichi Ochiai
Journal:  Eur J Anaesthesiol       Date:  2014-07       Impact factor: 4.330

4.  Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD.

Authors:  Akira Sezai; Mitsumasa Hata; Tetsuya Niino; Isamu Yoshitake; Satoshi Unosawa; Shinji Wakui; Haruka Kimura; Motomi Shiono; Tadateru Takayama; Atsushi Hirayama
Journal:  J Am Coll Cardiol       Date:  2011-08-23       Impact factor: 24.094

5.  Haloperidol prophylaxis for preventing aggravation of postoperative delirium in elderly patients: a randomized, open-label prospective trial.

Authors:  Shinji Fukata; Yasuji Kawabata; Ken Fujishiro; Yuichi Kitagawa; Kojiro Kuroiwa; Hirotoshi Akiyama; Marie Takemura; Masahiko Ando; Hideyuki Hattori
Journal:  Surg Today       Date:  2016-11-09       Impact factor: 2.549

6.  Delirium predicts 12-month mortality.

Authors:  Jane McCusker; Martin Cole; Michal Abrahamowicz; Francois Primeau; Eric Belzile
Journal:  Arch Intern Med       Date:  2002-02-25

7.  Perioperative Gabapentin Does Not Reduce Postoperative Delirium in Older Surgical Patients: A Randomized Clinical Trial.

Authors:  Jacqueline M Leung; Laura P Sands; Ningning Chen; Christopher Ames; Sigurd Berven; Kevin Bozic; Shane Burch; Dean Chou; Kenneth Covinsky; Vedat Deviren; Sakura Kinjo; Joel H Kramer; Michael Ries; Bobby Tay; Thomas Vail; Philip Weinstein; Stacey Chang; Gabriela Meckler; Stacey Newman; Tiffany Tsai; Vanessa Voss; Emily Youngblom
Journal:  Anesthesiology       Date:  2017-10       Impact factor: 7.892

8.  Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial.

Authors:  Melanie Gamberini; Daniel Bolliger; Giovanna A Lurati Buse; Christoph S Burkhart; Martin Grapow; Alexa Gagneux; Miodrag Filipovic; Manfred D Seeberger; Hans Pargger; Martin Siegemund; Thierry Carrel; Walter O Seiler; Manfred Berres; Stephan P Strebel; Andreas U Monsch; Luzius A Steiner
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

Review 9.  Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis.

Authors:  Chieko Mitaka; Toshifumi Kudo; Go Haraguchi; Makoto Tomita
Journal:  Crit Care       Date:  2011-10-27       Impact factor: 9.097

10.  The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C?

Authors:  Stuart G Baker; Barnett S Kramer
Journal:  BMC Med Res Methodol       Date:  2002-11-13       Impact factor: 4.615

View more
  2 in total

1.  Global Research and Scientific Publications on Dexmedetomidine Use in Adults for Anesthesia Care between 2001 and 2021: A Bibliometric Analysis.

Authors:  Rojnarin Komonhirun; Narut Ruananukun
Journal:  Curr Ther Res Clin Exp       Date:  2022-06-15

2.  Effects of subanaesthetic S-ketamine on postoperative delirium and cognitive function in elderly patients undergoing non-cardiac thoracic surgery: a protocol for a randomised, double-blinded, placebo-controlled and positive-controlled, non-inferiority trial (SKED trial).

Authors:  Wei Wei; Anyu Zhang; Lv Liu; Xi Zheng; Chunlin Tang; Ming Zhou; Yu Gu; Yonghua Yao
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.